NCT00198328View on ClinicalTrials.gov

Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma

PHASE3TerminatedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Head Neck Cancer
Interventions
COMBINATION_PRODUCT

Medpulser Electroporation with Bleomycin

Patients receive injections of Bleomycin Sulfate at a concentration of 1 U/ml per cm3 of tumor treatment area followed by electroporation.

PROCEDURE

Surgical Excision

Patients have their tumor surgically removed.

Trial Locations (1)

92121

Inovio Biomedical Corporation, San Diego

Sponsors
All Listed Sponsors
lead

Inovio Pharmaceuticals

INDUSTRY

NCT00198328 - Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma | Biotech Hunter | Biotech Hunter